NRXP Earnings

Quarterly EPS
$-0.15
Q3 2024
$-0.74
Q4 2024
$-0.34
Q1 2025
$-0.98
Q2 2025
$-0.27
Q3 2025
$0.01
Q4 2025
$-0.04
Q1 2026
$-0.44
Q2 2026
Latest Revenue1.1M
Latest Net Income-16520000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.441.1M-16520000+55.1%
Q1 2026-$0.041.1M-1430000+88.2%
Q4 2025$0.01983.0K360.0K+101.4%
Q3 2025-$0.27242.0K-5890000-80.0%
Q2 2025-$0.980-17581000-30.7%
Q1 2025-$0.340-5512000+54.1%
Q4 2024-$0.740-9078000-270.0%
Q3 2024-$0.150-1623000+79.7%
Q2 2024-$0.750-7897000
Q1 2024-$0.740-6528000
Q4 2023-$0.200-4332000
Q3 2023-$0.740-6062000
NRX Pharmaceuticals (NRXP) — Earnings